184021-91-8

Basic information

• Product Name: tert-Butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate
• Synonyms: tert-Butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate
• CAS NO: 184021-91-8
• Molecular Formula: C13H16N2O3
• Molecular Weight: 248.27774
• Mol File: 184021-91-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-Butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate(184021-91-8)
• EPA Substance Registry System: tert-Butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate(184021-91-8)

Safety Data

• Hazardous Substances Data: 184021-91-8(Hazardous Substances Data)

Upstream product

• 150544-04-0 6-amino-1,3-dihydro-indol-2-one 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

INDAZOLYL, BENZIMIDAZOLYL, BENZOTRIAZOLYL SUBSTITUTED INDOLMONE DERIVATIVES AS KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER

The present invention is directed to a compound is represented by Structural Formula (A):or a pharmaceutically acceptable salt therof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof.